Edition:
United States

Search Results  for 'MEDAa.ST'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Meda AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

"The Economy Matters" Report for MDABY: the economy's impact on MDABY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

01 Nov 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

MEDA AB (MDABY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

Wright Investors Service Comprehensive Report for Meda Ab

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

03 Aug 2016 Wright Reports 61 $75.00

Wright Industry Averages: Pharmaceuticals & Biotechnology (Sweden)

Wright Investors' Service Industry Averages - Pharmaceuticals & Biotechnology (Sweden). Wright Industry Averages provide calc...

21 Jun 2016 Wright Reports 56 $169.00

Meda AB: Upgraded to Average

20 Jun 2016 Sadif Analytics Prime 3 $10.00

Meda AB (MEDA A) - Financial Analysis Review

Meda AB (MEDA A) - Financial Analysis Review Summary Meda AB (Meda) is a pharmaceutical company that develops, manufactures a...

17 Jun 2016 GlobalData 94 $300.00

Meda AB (MEDA A) - Financial Analysis Review

Meda AB (MEDA A) - Financial Analysis Review Summary Meda AB (Meda) is a specialty pharmaceutical company that develops, manu...

28 Mar 2016 GlobalData 104 $300.00

Meda AB: Downgraded to Risky

15 Jan 2016 Sadif Analytics Prime 3 $10.00

Meda AB (MEDA A) - Financial Analysis Review

Meda AB (MEDA A) - Financial Analysis Review Summary Meda AB (Meda) is a specialty pharmaceutical company that develops, manu...

16 Dec 2015 GlobalData 114 $300.00